| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
2.76 0.01 (0%) |
12-11 16:00 |
|
Open: |
2.79 |
Pre close: |
2.75 |
Target:
|
3.53
|
|
High: |
2.79 |
Low: |
2.71 |
Resistance:
|
3.02
3.29
|
|
Volume: |
917,397 |
Market Cap: |
460M |
Support:
|
2.58
2.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.78
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
2.76 |
Signal(12,26,9): |
-0.04  |
|
MA(100): |
2.97 |
Stochastic Oscillator |
%K(14,3):
|
24.14 |
|
MA(250): |
3.40 |
%D(3): |
30.45 |
|
Average Volume(K) |
3-Month: |
240662
|
52-Week |
High:
|
4.71 |
|
10-Days: |
266410 |
Low: |
2.56 |
|
RSI |
RSI(14):
|
46.96 |
Change(%): |
-23.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.650 |
Return on Equity (ttm) |
-124.8 |
Shares Out. (M) |
166.64 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-102.4 |
Shares Float (M) |
165.97 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.09 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
440.6 |
% Held by Institutions |
145.00 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.540 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.61 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-90.19 |
P/S |
11498160128.00 |
|
Operating Margin |
-1524.81 |
Levered Free Cash Flow
(M) |
-54.46 |
P/CF |
-5.10 |
|
|
|
|
|
|
